Musclepharm Stock Number Of Employees
MusclePharm fundamentals help investors to digest information that contributes to MusclePharm's financial success or failures. It also enables traders to predict the movement of MusclePharm Pink Sheet. The fundamental analysis module provides a way to measure MusclePharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MusclePharm pink sheet.
MusclePharm |
MusclePharm Company Number Of Employees Analysis
MusclePharm's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current MusclePharm Number Of Employees | 21 |
Most of MusclePharm's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MusclePharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, MusclePharm is currently employing 21.0 people. This is 99.95% lower than that of the Food Products sector and 99.85% lower than that of the Consumer Staples industry. The number of employees for all United States stocks is 99.89% higher than that of the company.
MusclePharm Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MusclePharm's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of MusclePharm could also be used in its relative valuation, which is a method of valuing MusclePharm by comparing valuation metrics of similar companies.MusclePharm is currently under evaluation in number of employees category among its peers.
MusclePharm Fundamentals
| Revenue | 50.04 M | |||
| EBITDA | (7.07 M) | |||
| Net Income | (12.87 M) | |||
| Total Debt | 10.71 M | |||
| Cash Flow From Operations | (8.04 M) | |||
| Number Of Employees | 21 | |||
| Total Asset | 11.21 M | |||
| Retained Earnings | (205.54 M) | |||
| Working Capital | (30.11 M) | |||
| Net Asset | 11.21 M |
About MusclePharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MusclePharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MusclePharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MusclePharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with MusclePharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MusclePharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MusclePharm will appreciate offsetting losses from the drop in the long position's value.Moving against MusclePharm Pink Sheet
| 0.78 | AXP | American Express Earnings Call Today | PairCorr |
| 0.76 | FNMFO | Federal National Mortgage | PairCorr |
| 0.71 | WMT | Walmart Aggressive Push | PairCorr |
| 0.63 | MNPR | Monopar Therapeutics Trending | PairCorr |
| 0.46 | AVAL | Grupo Aval | PairCorr |
The ability to find closely correlated positions to MusclePharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MusclePharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MusclePharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MusclePharm to buy it.
The correlation of MusclePharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MusclePharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MusclePharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MusclePharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in MusclePharm Pink Sheet
If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |